Repetitive TMS for frontotemporal degeneration
Part of Brain & nervous system, Hormones & metabolism, Mental health clinical trials.
This trial tests whether repetitive transcranial magnetic stimulation (rTMS) can help people with frontotemporal lobar degeneration. It is a non-invasive brain stimulation technique that may improve symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a diagnosis of frontotemporal lobar degeneration (FTLD), including subtypes like behavioral variant, primary progressive aphasia, or related conditions.
- Your symptoms must be mild to moderate (global CDR plus NACC FTLD score of 1 or less).
- You cannot have other brain problems such as stroke, brain tumor, head injury, epilepsy, or fluid buildup in the brain.
- You cannot have metal implants in your head or electronic devices like a pacemaker.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a non-invasive brain stimulation technique called tACS (transcranial alternating current stimulation) in people with frontotemporal dementia. The goal is to see if it can improve symptoms like behavior and language problems.
This study tests whether a non-invasive brain stimulation technique called repetitive transcranial magnetic stimulation (rTMS), targeted precisely using brain imaging, can safely reduce the involuntary movements caused by some psychiatric medications. If you have tardive dyskinesia, this treatment might help improve your motor symptoms.
This trial tests a type of brain stimulation called theta burst repetitive transcranial magnetic stimulation (rTMS) to see if it can help improve movement problems caused by functional neurological disorder (FND). The study measures whether patients feel their symptoms improve after receiving this treatment.
This trial is testing a type of brain stimulation therapy called theta-burst rTMS to see if it helps with depression that hasn't improved with standard treatments. It also uses brain scans to predict who might respond best.
This study tests whether a non-invasive brain stimulation treatment called repetitive transcranial magnetic stimulation (rTMS) can help improve symptoms of Parkinson's disease. The treatment uses magnetic pulses applied to the head, and half of the participants will receive a sham (inactive) treatment to compare results.
This study tests whether a brain stimulation treatment called rTMS can improve symptoms in people with Alzheimer’s disease. It mainly looks at people with mild to moderate dementia and checks whether results differ based on how the treatment is applied.
Hear when a new FTD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.